Back
Schwab Fundamental U.S. Small CompanyETF Vs. Corbus Pharmaceuticals Holdings Industry Stock Comparison
Sell
34
FNDA
Schwab Fundamental U.S. Small CompanyETF
Last Price:
56.85
Seasonality Move:
3.48%
Buy
58
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
51.47
Seasonality Move:
-8.66%
Sell
34
Schwab Fundamental U.S. Small CompanyETF (FNDA)
is a Sell
Is Schwab Fundamental U.S. Small CompanyETF a Buy, Sell or Hold?
- The current Schwab Fundamental U.S. Small CompanyETF [FNDA] share price is $56.20. The Score for FNDA is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- FNDA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Corbus Pharmaceuticals Holdings (CRBP)
is a Buy
Is Corbus Pharmaceuticals Holdings a Buy, Sell or Hold?
- The current Corbus Pharmaceuticals Holdings [CRBP] share price is $52.71. The Score for CRBP is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- CRBP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FNDA Stock Price Chart
What is Schwab Fundamental U.S. Small CompanyETF's stock price today?
-
The Schwab Fundamental U.S. Small CompanyETF share price today is $56.20
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FNDA is experiencing buying pressure, which is a positive indicator for future bullish movement.
CRBP Stock Price Chart
What is Corbus Pharmaceuticals Holdings's stock price today?
-
The Corbus Pharmaceuticals Holdings share price today is $52.71
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRBP is experiencing selling pressure, which indicates risk of future bearish movement.
FNDA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.16 | Sell |
Relative Strength Index (14 RSI): | 42.69 | Sell |
Chaikin Money Flow: | 190081 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (55.79 - 58.25) | Sell |
Bollinger Bands (100): | (54.53 - 57.85) | Buy |
CRBP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.47 | Sell |
Relative Strength Index (14 RSI): | 46.19 | Sell |
Chaikin Money Flow: | -189174 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (52.01 - 58.85) | Sell |
Bollinger Bands (100): | (41.9 - 56.58) | Buy |
FNDA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 56.93 | Sell |
20-day SMA: | 57.43 | Sell |
50-day SMA: | 57.14 | Sell |
200-day SMA: | 55.17 | Buy |
8-day EMA: | 56.76 | Sell |
20-day EMA: | 57.13 | Sell |
50-day EMA: | 56.92 | Sell |
200-day EMA: | 54.96 | Buy |
CRBP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 54.34 | Sell |
20-day SMA: | 56.09 | Sell |
50-day SMA: | 55.43 | Sell |
200-day SMA: | 35.57 | Buy |
8-day EMA: | 54.19 | Sell |
20-day EMA: | 55.19 | Sell |
50-day EMA: | 53.87 | Sell |
200-day EMA: | 39.11 | Buy |
Schwab Fundamental U.S. Small CompanyETF Earnings Growth & FNDA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Corbus Pharmaceuticals Holdings Earnings Growth & CRBP Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.12 per share, an increase next quarter of $0.03 per share, an increase this year of $7.24 per share, and a decrease next year of $0.09 per share.
Schwab Fundamental U.S. Small CompanyETF Technical Analysis
Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
28 | 29 | 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Corbus Pharmaceuticals Holdings Technical Analysis
Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Aug | Sep | |||||||||
28 | 29 | 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |